Mannkind (MNKD) Capital Expenditures (QoQ) (2010 - 2026)
Mannkind (MNKD) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.61% |
| Dec 31, 2025 | 66.88% |
| Sep 30, 2025 | -155.68% |
| Jun 30, 2025 | 238.48% |
| Mar 31, 2025 | 70.98% |
| Dec 31, 2024 | 135.37% |
| Sep 30, 2024 | 108.17% |
| Jun 30, 2024 | -141.69% |
| Mar 31, 2024 | 401.38% |
| Dec 31, 2023 | -226.42% |
| Sep 30, 2023 | 109.79% |
| Jun 30, 2023 | -177.64% |
| Mar 31, 2023 | 6,256.30% |
| Dec 31, 2022 | -126.11% |
| Sep 30, 2022 | -3.00% |
| Jun 30, 2022 | 39.16% |
| Mar 31, 2022 | -65.50% |
| Dec 31, 2021 | 207.87% |
| Sep 30, 2021 | -197.17% |
| Jun 30, 2021 | 754.03% |